Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Authors: P E Nikolaou, N Mylonas, M Makridakis, M Makrecka-Kuka, A Iliou, S Zerikiotis, P Efentakis, N Kostomitsopoulos, R Vilskersts, C Zuurbier, A Latosinska, A Vlahou, G Dimitriadis, E K Iliodromitis, I Andreadou

Published: 2022-10-15

DOI: 10.1093/eurheartj/ehac544.2905

Source: Full article


Abstract

Abstract